Clinical Trial

Combined Circulatory and Dietary Interventions for Neuropathy

Study acronym: CDIN
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness of three different interventions in improving neuropathy symptoms in individuals aged 35-85 with moderate to severe neuropathy. The study will compare three treatment groups: Intraneural Facilitation® (INF®) therapy alone, INF® therapy combined with Neuro vascular index (NVI) food-guided elimination (NVIf), and NVIf alone. The aim is to determine which treatment results in the greatest improvement in neuropathy symptoms, including quality of life, sensory and pain improvements, and functional outcomes.
Trial Details
NCT Number NCT07213843
Lead Sponsor Loma Linda University
Conditions Diabete Type 2, Neuropathy, Painful
Enrollment 60 participants
Start Date 2026-10-01
Primary Completion 2028-10-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-09